Overview
Oculoectodermal syndrome (OES), also known as oculo-ectodermal syndrome or epidermal nevus syndrome with ocular involvement, is a rare congenital disorder characterized by the combination of epibulbar dermoids (benign growths on the surface of the eye) and aplasia cutis congenita (areas of absent skin, typically on the scalp). The condition primarily affects the eyes and skin (ectodermal tissues), and has been associated with activating mutations in the KRAS gene, occurring as a mosaic (postzygotic somatic) event rather than being inherited from a parent. Key clinical features include epibulbar or limbal dermoids, which are benign choristomas found on the eye surface that may affect vision, and areas of congenital skin deficiency most commonly located on the scalp. Additional features that have been reported in some patients include skin tags or accessory tragi (small skin appendages near the ears), coloboma of the eyelid, and occasionally other ectodermal abnormalities. Some patients may also present with pigmented skin lesions or organoid nevi. The severity and combination of features can vary considerably between affected individuals. There is no specific cure for oculoectodermal syndrome. Management is symptomatic and supportive, tailored to the individual's clinical manifestations. Surgical removal of epibulbar dermoids may be considered if they impair vision or for cosmetic reasons. Aplasia cutis congenita lesions on the scalp may require wound care and occasionally surgical repair. Regular ophthalmologic and dermatologic follow-up is recommended. Genetic counseling should be offered to affected families, though the condition typically arises sporadically due to somatic mosaicism.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Oculoectodermal syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Oculoectodermal syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Oculoectodermal syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Oculoectodermal syndrome.
Community
No community posts yet. Be the first to share your experience with Oculoectodermal syndrome.
Start the conversation →Latest news about Oculoectodermal syndrome
No recent news articles for Oculoectodermal syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Oculoectodermal syndrome
What is Oculoectodermal syndrome?
Oculoectodermal syndrome (OES), also known as oculo-ectodermal syndrome or epidermal nevus syndrome with ocular involvement, is a rare congenital disorder characterized by the combination of epibulbar dermoids (benign growths on the surface of the eye) and aplasia cutis congenita (areas of absent skin, typically on the scalp). The condition primarily affects the eyes and skin (ectodermal tissues), and has been associated with activating mutations in the KRAS gene, occurring as a mosaic (postzygotic somatic) event rather than being inherited from a parent. Key clinical features include epibulb
How is Oculoectodermal syndrome inherited?
Oculoectodermal syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Oculoectodermal syndrome typically begin?
Typical onset of Oculoectodermal syndrome is neonatal. Age of onset can vary across affected individuals.